Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides https://www.biorxiv.org/content/10.1101/2023.01.05.522964v1?med=mas
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides https://www.biorxiv.org/content/10.1101/2023.01.05.522964v1?med=mas